The promise of selective aldosterone synthase inhibition for the management of resistant hypertension - KIVIRID

The promise of selective aldosterone synthase inhibition for the management of resistant hypertension

Authors: Massimo Volpe, Carlo Patrono

Published: 2022-12-21

DOI: 10.1093/eurheartj/ehac754

Source: Full article

Abstract

No abstract found.